nodes	percent_of_prediction	percent_of_DWPC	metapath
Bifonazole—CYP17A1—zona fasciculata of adrenal gland—adrenal gland cancer	0.432	0.442	CbGeAlD
Bifonazole—CYP17A1—zona glomerulosa of adrenal gland—adrenal gland cancer	0.378	0.387	CbGeAlD
Bifonazole—CYP2C19—urine—adrenal gland cancer	0.0343	0.0352	CbGeAlD
Bifonazole—CYP2E1—urine—adrenal gland cancer	0.0252	0.0258	CbGeAlD
Bifonazole—CYP3A4—urine—adrenal gland cancer	0.0203	0.0208	CbGeAlD
Bifonazole—CYP17A1—adrenal cortex—adrenal gland cancer	0.0183	0.0188	CbGeAlD
Bifonazole—CYP17A1—gonad—adrenal gland cancer	0.0152	0.0156	CbGeAlD
Bifonazole—CYP17A1—adrenal gland—adrenal gland cancer	0.0132	0.0136	CbGeAlD
Bifonazole—CYP19A1—gonad—adrenal gland cancer	0.00918	0.00941	CbGeAlD
Bifonazole—CYP19A1—adrenal gland—adrenal gland cancer	0.008	0.0082	CbGeAlD
Bifonazole—CYP2B6—adrenal cortex—adrenal gland cancer	0.00712	0.00729	CbGeAlD
Bifonazole—CYP2B6—gonad—adrenal gland cancer	0.0059	0.00604	CbGeAlD
Bifonazole—Fenbufen—PTGS2—adrenal gland cancer	0.00581	0.433	CrCbGaD
Bifonazole—CYP2B6—adrenal gland—adrenal gland cancer	0.00514	0.00526	CbGeAlD
Bifonazole—Oxaprozin—PTGS2—adrenal gland cancer	0.00505	0.377	CrCbGaD
Bifonazole—CYP2E1—adrenal gland—adrenal gland cancer	0.00482	0.00494	CbGeAlD
Bifonazole—Clotrimazole—ABCB1—adrenal gland cancer	0.00254	0.19	CrCbGaD
Bifonazole—CYP17A1—Glucocorticoid biosynthesis—POMC—adrenal gland cancer	0.000988	0.0956	CbGpPWpGaD
Bifonazole—CYP19A1—Ovarian Infertility Genes—NR5A1—adrenal gland cancer	0.000825	0.0798	CbGpPWpGaD
Bifonazole—CYP17A1—Androgen biosynthesis—POMC—adrenal gland cancer	0.000766	0.0741	CbGpPWpGaD
Bifonazole—CYP51A1—Endogenous sterols—POMC—adrenal gland cancer	0.000499	0.0483	CbGpPWpGaD
Bifonazole—CYP17A1—Endogenous sterols—POMC—adrenal gland cancer	0.000425	0.0411	CbGpPWpGaD
Bifonazole—CYP19A1—FSH signaling pathway—PRKACA—adrenal gland cancer	0.000415	0.0401	CbGpPWpGaD
Bifonazole—CYP51A1—SREBP signalling—PRKACA—adrenal gland cancer	0.00038	0.0368	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of steroid hormones and vitamin D—POMC—adrenal gland cancer	0.000318	0.0308	CbGpPWpGaD
Bifonazole—CYP19A1—Endogenous sterols—POMC—adrenal gland cancer	0.000257	0.0249	CbGpPWpGaD
Bifonazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000255	0.0246	CbGpPWpGaD
Bifonazole—CYP51A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000232	0.0224	CbGpPWpGaD
Bifonazole—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000197	0.0191	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—adrenal gland cancer	0.000193	0.0186	CbGpPWpGaD
Bifonazole—CYP51A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000188	0.0182	CbGpPWpGaD
Bifonazole—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000185	0.0179	CbGpPWpGaD
Bifonazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000176	0.017	CbGpPWpGaD
Bifonazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000172	0.0167	CbGpPWpGaD
Bifonazole—CYP17A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00016	0.0155	CbGpPWpGaD
Bifonazole—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00014	0.0135	CbGpPWpGaD
Bifonazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000139	0.0135	CbGpPWpGaD
Bifonazole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000119	0.0116	CbGpPWpGaD
Bifonazole—CYP51A1—Biological oxidations—POMC—adrenal gland cancer	9.98e-05	0.00966	CbGpPWpGaD
Bifonazole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.68e-05	0.00937	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	9.63e-05	0.00932	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—SDHB—adrenal gland cancer	8.93e-05	0.00864	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	8.87e-05	0.00858	CbGpPWpGaD
Bifonazole—CYP17A1—Biological oxidations—POMC—adrenal gland cancer	8.49e-05	0.00821	CbGpPWpGaD
Bifonazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	8.4e-05	0.00813	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.19e-05	0.00792	CbGpPWpGaD
Bifonazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	8e-05	0.00774	CbGpPWpGaD
Bifonazole—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.67e-05	0.00742	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—SDHB—adrenal gland cancer	7.59e-05	0.00734	CbGpPWpGaD
Bifonazole—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.51e-05	0.00727	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.03e-05	0.0068	CbGpPWpGaD
Bifonazole—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.22e-05	0.00602	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	6.19e-05	0.00599	CbGpPWpGaD
Bifonazole—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.09e-05	0.00589	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.97e-05	0.00578	CbGpPWpGaD
Bifonazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.8e-05	0.00561	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—RRM1—adrenal gland cancer	5.75e-05	0.00556	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—SDHD—adrenal gland cancer	5.75e-05	0.00556	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	5.64e-05	0.00545	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	5.54e-05	0.00536	CbGpPWpGaD
Bifonazole—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	5.35e-05	0.00517	CbGpPWpGaD
Bifonazole—CYP19A1—Biological oxidations—POMC—adrenal gland cancer	5.14e-05	0.00498	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.96e-05	0.0048	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—RRM1—adrenal gland cancer	4.89e-05	0.00473	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—SDHD—adrenal gland cancer	4.89e-05	0.00473	CbGpPWpGaD
Bifonazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.7e-05	0.00455	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—SDHB—adrenal gland cancer	4.6e-05	0.00445	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—MED12—adrenal gland cancer	4.29e-05	0.00415	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	4.07e-05	0.00394	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.83e-05	0.00371	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—MED12—adrenal gland cancer	3.65e-05	0.00353	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.62e-05	0.0035	CbGpPWpGaD
Bifonazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	3.49e-05	0.00337	CbGpPWpGaD
Bifonazole—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	3.3e-05	0.0032	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.26e-05	0.00315	CbGpPWpGaD
Bifonazole—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	3.24e-05	0.00313	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	3.23e-05	0.00312	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—PRKACA—adrenal gland cancer	3.13e-05	0.00303	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.06e-05	0.00296	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—SDHD—adrenal gland cancer	2.96e-05	0.00287	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—RRM1—adrenal gland cancer	2.96e-05	0.00287	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—SDHB—adrenal gland cancer	2.95e-05	0.00286	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—SDHB—adrenal gland cancer	2.89e-05	0.0028	CbGpPWpGaD
Bifonazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	2.83e-05	0.00273	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	2.71e-05	0.00262	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—PRKACA—adrenal gland cancer	2.66e-05	0.00257	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.6e-05	0.00252	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—GNAS—adrenal gland cancer	2.54e-05	0.00245	CbGpPWpGaD
Bifonazole—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	2.5e-05	0.00241	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—ABCB1—adrenal gland cancer	2.49e-05	0.00241	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.41e-05	0.00233	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—SDHB—adrenal gland cancer	2.23e-05	0.00216	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—MED12—adrenal gland cancer	2.21e-05	0.00214	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—GNAS—adrenal gland cancer	2.16e-05	0.00209	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—ABCB1—adrenal gland cancer	2.12e-05	0.00205	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.98e-05	0.00191	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—RRM1—adrenal gland cancer	1.9e-05	0.00184	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—SDHD—adrenal gland cancer	1.9e-05	0.00184	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—SDHD—adrenal gland cancer	1.86e-05	0.0018	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—RRM1—adrenal gland cancer	1.86e-05	0.0018	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.76e-05	0.0017	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—POMC—adrenal gland cancer	1.71e-05	0.00165	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—PRKACA—adrenal gland cancer	1.61e-05	0.00156	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.58e-05	0.00152	CbGpPWpGaD
Bifonazole—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	1.5e-05	0.00145	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—POMC—adrenal gland cancer	1.45e-05	0.0014	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—RRM1—adrenal gland cancer	1.44e-05	0.00139	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—SDHD—adrenal gland cancer	1.44e-05	0.00139	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—MED12—adrenal gland cancer	1.42e-05	0.00137	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—MED12—adrenal gland cancer	1.39e-05	0.00134	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—PTGS2—adrenal gland cancer	1.36e-05	0.00132	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—SDHB—adrenal gland cancer	1.34e-05	0.0013	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—GNAS—adrenal gland cancer	1.31e-05	0.00126	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—ABCB1—adrenal gland cancer	1.28e-05	0.00124	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—PTGS2—adrenal gland cancer	1.16e-05	0.00112	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—MED12—adrenal gland cancer	1.07e-05	0.00104	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	1.04e-05	0.001	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	1.01e-05	0.000981	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.59e-06	0.000927	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—POMC—adrenal gland cancer	8.8e-06	0.000851	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—RRM1—adrenal gland cancer	8.65e-06	0.000837	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—SDHD—adrenal gland cancer	8.65e-06	0.000837	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—GNAS—adrenal gland cancer	8.39e-06	0.000812	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	8.23e-06	0.000796	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—GNAS—adrenal gland cancer	8.22e-06	0.000795	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	8.06e-06	0.00078	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	7.82e-06	0.000757	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.65e-06	0.00074	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—PTGS2—adrenal gland cancer	7.02e-06	0.000679	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—MED12—adrenal gland cancer	6.45e-06	0.000624	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—GNAS—adrenal gland cancer	6.34e-06	0.000613	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	6.22e-06	0.000602	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—POMC—adrenal gland cancer	5.65e-06	0.000546	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—POMC—adrenal gland cancer	5.53e-06	0.000535	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	4.7e-06	0.000455	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	4.51e-06	0.000436	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	4.41e-06	0.000427	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—POMC—adrenal gland cancer	4.27e-06	0.000413	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—GNAS—adrenal gland cancer	3.81e-06	0.000369	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	3.74e-06	0.000362	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	3.4e-06	0.000329	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—POMC—adrenal gland cancer	2.57e-06	0.000248	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.05e-06	0.000198	CbGpPWpGaD
